Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02698722 · ClinicalTrials.gov registry record · NA

A Video Decision Support Tool to Assist Elderly Patients in ESRD Treatment Decision-making

A NA study of Chronic Kidney Disease and Decision Making, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02698722: Completed NA study of Chronic Kidney Disease and Decision Making, sponsored by Massachusetts General Hospital.

NCT02698722 is a NA study of Chronic Kidney Disease and Decision Making that has completed, run by Massachusetts General Hospital. The registered enrollment target is 100 participants, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02698722, a NA study of Chronic Kidney Disease and Decision Making, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

In the United States, it is estimated that there are approximately 630,000 patients who have ESRD with two-thirds of those patients subsequently receiving maintenance dialysis. Studies have demonstrated that the initiation and timing of dialysis for those with ESRD seem to vary widely regionally - confirming the uncertainty of the benefits of chronic dialysis in this population Pre-dialysis education programs inform patients of all of their options allowing them to choose renal replacement therapy that is most consistent with their wishes. Recent evidence has supported using different methods of delivering education including videos to complement standard clinical care practices to promote informed decision making. This proposed study will serve to examine the efficacy of a dialysis modality video decision support tool to inform chronic kidney disease patients of different dialytic and non-dialytic therapies.

Interventions

  • OTHER End-stage renal disease treatment options

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2016-07-19
Est. Completion 2019-03-22
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT02698722 record still lists

NCT02698722 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which End-stage renal disease treatment options is the first listed.

NCT02698722 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02698722 about?

NCT02698722 is a clinical study titled "A Video Decision Support Tool to Assist Elderly Patients in ESRD Treatment Decision-making". In the United States, it is estimated that there are approximately 630,000 patients who have ESRD with two-thirds of those patients subsequently receiving maintenance dialysis. Studies have demonstrated that the initiation and timing of dialysis for those with ESRD seem to vary widely regionally - c...

What is the current status of trial NCT02698722?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2016-07-19. Estimated completion is 2019-03-22.

What conditions does trial NCT02698722 study?

This clinical trial studies the following conditions: Chronic Kidney Disease, Decision Making.

What interventions are being tested in trial NCT02698722?

The interventions under investigation include: End-stage renal disease treatment options (OTHER).

Who is sponsoring clinical trial NCT02698722?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02698722 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02698722's enrollment target sits among peer trials

100 58th of 101 higher than 43 of 101 other Chronic Kidney Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02698722, the US trial registry maintained by the National Library of Medicine. NCT02698722 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.